- Bedoelde u
- a. dans
Zoekresultaten - 2 results
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
to estimate the budgetary impact of reimbursement of direct-acting antivirals (DAA s). In Belgium, the restricted reimbursement criteria are mainly guided by regional seroprevalence estimates of 0.87% ...
Distribution of HCV genotypes in Belgium from 2008 to 2015.
possible impact of migration from endemic regions and prior to the increasing use of highly potent direct-acting antiviral (DAA) agents. Health Topics: Hepatitis A, B, C, D en E Hepatitis A, B, C, D and ...